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In the current review article, the studies conducted to investigate the anti-inflammatory activity of Aquilaria species are 
compiled and summarized. Since inflammation is the underlying cause of many diseases, the encounter of effective and safe 
biomedical anti-inflammatory compounds has become the focus of recent researches. Aquilaria species were known to 
possess a wide spectrum of pharmacological activities, among which anti-inflammatory activity has been reported in many 
in vitro and in vivo studies. Chromones, sesquiterpenoids, flavonoids, benzophenones and phorbol esters were the major 
anti-inflammatory compounds isolated from Aquilaria species. The objective of this review paper is to extend researches on 
the anti-inflammatory activity of different parts of Aquilaria species and support their future use in natural pharmaceutical 
preparations for the treatment of inflammation-associated conditions. 
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Introduction 
Inflammation is a vital biological phenomenon that 
occurs in response to internal and external injurious 
stimuli to mitigate foreign triggers, initiate damaged 




Although the role of inflammation is to safeguard 
the body, inflammation has been proven to be among 
the underlying etiologies of chronic and degenerative 
diseases such as diabetes, atherosclerosis, rheumatoid 
arthritis, cancer and cardiovascular diseases
2,3
. 
The most common drugs for the treatment of 
inflammatory disorders are non-steroidal anti-
inflammatory drugs (NSAIDs) and corticosteroids. 
However, high doses and prolonged use of synthetic 
anti-inflammatory medications may lead to intolerable 
side effects, most commonly, gastrointestinal 
bleeding. Across the world, traditional medicines in 
the form of herbal drinks were known to relieve 
inflammation. Accordingly, the discovery of effective 
and safe bio-based alternative compounds for the 
prevention and treatment of inflammation has 
attracted the attention of researchers, aiming to 
obviate the adverse effects of synthetic drugs.  
Aquilaria is a tropical evergreen tree that belongs 
to family Thymelaeaceae and is native to Southeast 
Asian rainforests and some parts of China and India
4
. 
The genus embraces 47 species, among which 22 are 
stated as accepted in The Plant List
4
. The tree is 
famous for its resinous and fragrant heartwood known 
as agarwood that is commonly used in religious 
ceremonies, perfumes and traditional Ayurvedic 
remedies. The dark fragrant agarwood occurs 
naturally in response to natural injuries such as 
lightning, insects and mould attacks
5
. However, the 
economic interest in agarwood has encouraged the 









production can be induced by physical means such as 
nailing and cutting, chemical means or fungi
5
. 
Besides, other parts of the tree became targets for the 
discovery of secondary metabolites and bioactive 
compounds. In the comprehensive ethnobotanical 
reviews, of Wang et al.
6
 and Hashim et al.
7
, the 
phytochemicals found in Aquilaria species and their 
pharmacological actions were documented. The most 
common phytochemicals found in Aquilaria species 
were alkaloids, tannins, saponins, terpenoids, 
flavonoid glycosides, sesquiterpenes and 2-(2-
phenylethyl) chromone derivatives
6,7
. Extracts of 
different parts of the tree and the isolated compounds 
were reported to exert several pharmacological 














 effects. Of particular 
interest, the present report aims to provide a 
comprehensive review of the anti-inflammatory 
activity of Aquilaria extracts and the species-isolated 
compounds, tested in vitro and in vivo. The 
information is important to researchers interested in 
further exploration of the anti-inflammatory activity 
of the plant. 
 
In vitro and in vivo models for studying anti-inflammatory 
effects  
Based on the pathophysiology and the apparent 
signs of inflammation, many in vitro tests and in vivo 
animal models have been approved to affirm the 
potential anti-inflammatory activity of newly 
discovered agents. Human macrophages and 
polymorph nuclear neutrophils (PMNs) are the major 
cells involved in the pathogenesis of inflammatory 
diseases. The aberrant stimulation of the macrophages 
induces the release of pro-inflammatory mediators 
such as NF-kβ, TNFα, IL6, reactive oxygen species 
(ROS), superoxide anions and proteases
20–22
. All 
above mentioned inflammatory molecules are 
considered possible targets for anti-inflammatory 
drugs. Inflammation is also associated with elevation 
of nitric oxide (NO) levels and protein denaturation. 
Therefore, the subsidence of NO levels and the 
inhibition of egg albumin or Bovine Serum Albumin 
(BSA) denaturation have been widely applied as in 
vitro screening assays for anti-inflammatory action.  
Accordingly, several herbal extracts and 
compounds are thought to be able to reduce pro-
inflammatory mediators, diminish NO levels or 
inhibit protein denaturation, and thus can be accepted 
as new potential anti-inflammatory agents. At in vitro 
level, lipopolysaccharide (LPS)-activated macrophages 
RAW 264.7 has been broadly used as a cell line 
model to study inflammation and identify anti-
inflammatory compounds. 
Animal models were extensively used in 
biomedical research to study the pharmacological and 
toxicological effects of anti-inflammatory drugs. The 
complex cascade in the pathogenesis of inflammation 
involves interaction between leucocytes, blood 
vessels and tissue cells. Increased permeability of 
blood vessels occurs accompanied by exudation of 
fluid from the blood into interstitial spaces and 
infiltration of leukocytes into the tissues
2,23 
resulting 
in the five hallmark signs of inflammation: redness, 
heat, swelling, pain and loss of function
1
. The 
reduction in vascular permeability and neutrophil 
infiltration which purges in the form of signs 
suppression was assessed in vivo among different 
animal models, most commonly, Xylene-induced ear 
swelling and carrageenan-induced paw oedema in 
mice
19
. Recently, the zebrafish animal model was 
used due to its morphological and physiological 
similarities to mammals and its high genetic 
similarities with humans. Yang et al.
24
 suggested that 
the zebrafish LPS (Lipopolysaccharide) in vivo 
inflammation model is a promising screening model 
that can be applied to study suppressors of 
inflammation. 
 
Studies on the anti-inflammatory activity of Aquilaria species 
Evidence in literature confirmed that extracts of 
different parts of Aquilaria species and some of the 
purified compounds demonstrate noticeable anti-
inflammatory potential. Dried Aquilaria leaves have 
gained wide popularity as traditional herbal tea in 
Asian countries. It was reported that tea processed 
from Aquilaria species is applied in traditional 
medicine to promote health and relief morbid 
conditions including inflammatory-related disorders
25
. 
Based on previous studies, the chemical constituents 
of different parts of Aquilaria species include 2-(2-
phenylethyl) chromones, fatty acids, benzophenones, 
flavonoids, terpenoids, and esters
6,7
. The presence of 
these compounds in herbal extracts is thought to be 
responsible for several pharmacological actions 
including anti-inflammatory. Conversely, the review 
on the anti-inflammatory activity of Aquilaria species 
is still incomprehensive. Therefore, this paper aims to 
compile the findings of previous studies conducted to 
investigate the anti-inflammatory activity in vivo and 
in vitro of different Aquilaria species. Four species 




dominate this review for being the most popular 
species documented in various reports; and with 
proven anti-inflammatory activity, namely, Aquilaria 
sinensis, Aquilaria malaccensis, Aquilaria agallocha 
and Aquilaria crassna. The findings of the in vitro 
and in vivo studies are summarized in Tables 1-2, 
respectively. The chemical structures of the  
identified compounds in Aquilaria species that 
demonstrated anti-inflammatory activity are shown  
in Fig. 1. 
 
Table 1 — In vitro anti-inflammatory studies on Aquilaria species 
Part  Extract/ compounds Experimental protocol  Quantitative response Ref. 
Aquilaria sinensis 
Leaves Ethanolic leaf extract: 50, 100, and 200 µg/mL Inhibition of LPS-induced 
NO release from mouse 
peritoneal macrophages 
IC50= 80.4 µg/mL 
Positive control: hydrocortisone 
(IC50= 0.1 µM) 
19 
(1) Aquilarinoside A  
(2) Iriflophenone  
(3) Mangiferin 
(4) 7-b –D-glucoside of 5-O-methylapigenin 
(5) 5-O-xylosylglycoside of 7-O-methylapigenin 
(6) Luteolin  
(7) Genkwanin  








(1) IC50= 89.92 µmol/L 
(2) IC50= 52.59 µmol/L 
(3) IC50= 50.34 µmol/L 
(4) IC50= 61.25 µmol/L 
(5) IC50= 293.06 µmol/L 
(6) IC50= 2.03 µmol/L 
(7) IC50= 265.41 µmol/L 
(8) IC50= 0.80 µmol/L 
Positive control: NA 
26 
 
(9) Aquisiflavoside Inhibition of LPS-induced 
NO production in RAW 
264.7 cells 
 
(9) IC50= 34.95 µM 







(10) Aquilarone A  
(11) Aquilarone B  
(12) Aquilarone C 
(13) Aquilarone D  
(14) Aquilarone E 
(15) Aquilarone F  
(16) Aquilarone G  
(17) Aquilarone H  
(18) Aquilarone I 
(19) (Known analogue) 
(20) (Known analogue) 
 
Inhibition of LPS-induced 




(10) IC50= 9.03 µM 
(11) IC50= 5.12 µM 
(12) IC50= 7.71 µM 
(13) IC50= 7.49 µM 
(14) IC50= 22.26 µM 
(15) IC50= 13.09 µM 
(16) IC50= 7.94 µM 
(17) IC50= 5.95 µM 
(18) IC50= 7.59 µM 
(19) IC50= 7.94 µM 
(20) IC50= 6.59 µM 





methoxyphenyl) ethyl] chromone 
(22) 5_,6_-epoxy-7_,8_,30-trihydroxy-40-
methoxy-2-(2-phenylethyl)chromone 
Inhibition of LPS-induced 
NO production in RAW 
264.7 cells 
 
(21) IC50= 4.6 µM 
(22) IC50= 84 µM 
Positive control: aminoguanidine 







Inhibition of LPS-induced 
NO production in RAW 
264.7 cells 
(23) IC50= 8.1 µM 
Positive control: aminoguanidine 







phenylethyl)-5,6,7,8- tetrahydrochromone  
(27) [29], 8-chloro-2-(2-phenylethyl)-5,6,7-
trihydroxy-5,6,7,8- tetrahydrochromone 
(28) [4], 8-dihydroxy-2-(2-phenylethyl) chromone  




Inhibition of LPS-induced 
NO production in RAW 
264.7 cells 
(24) IC50= 4.5 µM 
(25) IC50= 7.3 µM 
(26) IC50= 3.8 µM 
(27) IC50= 4.5 µM 
(28) IC50= 6.4 µM 
(29) IC50= 1.6 µM 
Positive control: indomethacin 
(IC50 = 23.6 µM) 
31 
(Contd.) 




Table 1 — In vitro anti-inflammatory studies on Aquilaria species (Contd.) 
Part  Extract/ compounds Experimental protocol  Quantitative response Ref. 
Aquilaria sinensis 
 (30) (+)-Aquisinenone A  
(31) (-)-Aquisinenone A  
(32) 4′-methoxyaquisinenone A  
(33) (+)-Aquisinenone B  
(34) (-)-Aquisinenone B 
(35) (+)-6″-hydroxy-4′,4‴-dimethoxyaquisinenone 
B 
(36) (-)-Aquisinenone D 
(37) (+)-4′-demethoxyaquisinenone D 
(38) (-)-4′-demethoxyaquisinenone D 
(39) (-)-Aquisinenone F 
(40) (−)-Aquisinenone G 
(41) (+)-4′-methoxyaquisinenone G 
 
LPS-induced NO production 
in  
RAW 264.7 cells 
 
(30) IC50= 11.5 µM 
(31) IC50= 7.6 µM 
(32) IC50= 9.3 µM 
(33) IC50= 8.8 µM 
(34) IC50= 8.6 µM 
(35) IC50= 10.5 µM 
(36) IC50= 7 µM 
(37) IC50= 8.5 µM 
(38) IC50= 8.5 µM 
(39) IC50= 12 µM 
(40) IC50= 11.4 µM 
(41) IC50= 8 µM 
Positive control: GYF-17  
(IC50= 4.4 µM) 
32 
  (42) 5,6-dihydroxy-2-[2-(3´-hydroxy-4´-









Luciferase activity in 
lipopolysaccharide (LPS)-
induced NF-κB activation in 
RAW 264.7/Luc-P1 cells 
 
(42) 0.74  
(43) 0.54 
(44) 0.31  
(45) 0.38 
(46) 0.55 





 (49) Aquisinenone H 
(50) Aquisinenone I 
(51) 7″-Methoxyaquisinenone I 
(52) 4′,7″-Dimethoxyaquisinenone I 
(53) Aquisinenone K 
(54) 4′,4‴-Dimethoxyaquisinenone K 
(55) Aquisinenone L  
(56) Aquisinenone M  
(57) Aquisinenone O 
(58) 7,4′-Dimethoxyaquisinenone O 
(59) 2′-di-(2-phenylethyl)-8,6′-dihydroxy-5,5′-
bichromone 
LPS-induced NO production 
in RAW  
264.7 cells 
 
(49) IC50= 4.3 µM 
(50) IC50= 1.9 µM 
(51) IC50= 1.6 µM 
(52) IC50= 5.8 µM 
(53) IC50= 0.7 µM 
(54) IC50= 0.6 µM 
(55) IC50= 8.0 µM 
(56) IC50= 37.1 µM 
(57) IC50= 7.6 µM 
(58) IC50= 2.3 µM 
(59) IC50= 7.4 µM 
Positive control: indomethacin 




(60) 3’-O-Geranylpolloin  
(61) 7-Hydroxy-6-methoxy-2- (2-phenylethyl) 
chromone 
(62) 5-Hydroxy-7,31,41-trimethoxyflavone 
(63) Velutin  
(64) 3’-Hydroxygenkwanin 
(65) Sakuranetin 
(66) 6,7-Dimethoxy-2-(2-phenylethyl) chromone 
(67) Ergosta-4,6,8(14),22-tetraen-3-one 
 
Superoxide anion (SOA) 
generation, Elastase release 
in fMLP/CB-activated 
human neutrophils 
(60) IC50= 12.51, 3.91 µM 
(61) IC50= 4.62 µM 
(62) IC50= 4.69 µM 
(63) IC50= 1.78, 4.26 µM 
(64) IC50= 7.96, 4.56 µM 
(65) IC50= 1.74 µM 
(66) IC50= 11.54 µM 
(67) IC50= NA, 15.25 µM 
Positive control (SOA 
inhibition): 
diphenyleneiodonium  
(IC50= 1.73 µM) 
Positive control (Elastase 
release inhibition): 
phenylmethylsulfonyl fluoride 
(IC50= 199.6 µM) 
 
21 
    (Contd.) 








Table 1 — In vitro anti-inflammatory studies on Aquilaria species (Contd.) 
Part  Extract/ compounds Experimental protocol  Quantitative response Ref. 
Aquilaria sinensis    
Flower buds Methanolic flower bud extract: 100 ug/mL 
(68) Aqulasides B 
(69) Aqulasides C 
 
Inhibition of iNOS activity 
Inhibition of NF-KB-
mediated transcription in 
SW1353 cells 
 
Extract: 22% inhibition of iNOS 
Positive control: parthenolide 
(97% at 100 ug/mL) 
(68) 31% at 100 µM 
(69) 60% at 100 µM 
Positive control: parthenolide 
(83% at 2.5 ug/mL) 
35 
Pericarp (63) Velutin 




induced NF-κB activation by 
macrophages  
(63) IC50= 23.36 µM 
(70) IC50= 25.58 µM 
(71) IC50= 11.51 µM 
Positive control: NA 
36 
Aquilaria malaccensis 
Leaves Ethanolic leaf extract: 16000 µg/mL 
Hexanoic leaf extract: 16000 µg/mL 
Supercritical fluid leaf extraction: 16000 µg/ML 










(80) 12-O-deoxyphorbol 13-decanoate 
(81) mellerin A. 
 
Inhibition of elastase 
release by fMLP/CB 
stimulated human 
neutrophils 
(79) IC50= 2.7 µM 
(80) IC50= 0.8 µM 
(81) IC50= 2.1 µM 
Positive Control: PI3K inhibitor 
LY294002 (IC50= 3.3 μM) 
39 
Aquilaria agallocha 
Agarwood  Oil: 100, 250, and 500 mcg/mL Human red blood cell 
membrane stabilization 
method 
Protection of human RBC in 
hypotonic solution ranging from 
39.66 to 78.50%  






Oil: 100, 250, and 500 µg/mL 
 
BSA denaturation assay 23.68, 48.21, and 56.71% 
inhibition of protein denaturation 
Positive control: diclofenac (39.58, 
75.83, and 77.51% ) 
34.09, 36.95, and 43.13% 





Ethanolic extract: 100, 250, and 500 µg/mL 
 




Agarwood Ethyl acetate extract: 1.5 mg/mL LPS-induced TNF-α 
production by human 
polymorphonuclear cells 
(hPBMC)  
1.5 mg/mL significantly reduced 
TNF-α level. 
Positive control: NA 
44 
 
Table 2 — In vivo anti-inflammatory studies on Aquilaria species 
Part  Extracts/ compounds (Dose) Experimental protocol Quantitative/ qualitative Response Ref. 
Aquilaria sinensis 
Leaves Ethanolic extract  
(424 and 848 mg/ kg) 
 
Xylene-induced ear swelling 
(ICR mice)  
Carrageenan-induced paw 
oedema (ICR mice) 
CMC-Na induced leukocyte 
migration (ICR mice) 
31.4 and 49.50% inhibition of ear swelling  
Positive control: indomethacin 20 mg/kg (63.9%) 
24.34 and 16.40 inhibition of paw oedema 
Positive control: indomethacin 20 mg/kg (14.76%) 
68.8 and 90.6% inhibition of leukocytes migration 




Leaves Ethanolic extract (200 and  
400 mg/kg) 
Freund’s adjuvant-induced 
paw oedema (Rats)  
21.20 and 25.34% inhibition in paw oedema on  
day 21 
Positive control: ibuprofen 50 mg/kg, p.o. 
(42.12%) 
43 
    
(Contd.) 




Table 2 — In vivo anti-inflammatory studies on Aquilaria species (Contd.) 
Part  Extracts/compounds (Dose) Experimental protocol Quantitative/ qualitative Response Ref. 
Aquilaria sinensis    
Agarwood Ethyl acetate extract orally 
(50, 100, and 200 mg/kg) 
 
Carrageenan induced paw 
oedema (Wister Rats)  
Cotton pellets induced 
granuloma (Wister Rats) 
51.38, 55.09, and 56.25% inhibition in paw 
oedema  
Positive control: diclofenac Na 25 mg/kg, p.o  
(% of inhibition not specified) 
43.46, 68.24, and 77.18% reduction in granuloma 
weight  




Oil (125 and 250 mg/kg)  
 
Freund’s adjuvant-induced 
paw oedema (Rats) 
18.12 and 27.88% inhibition in paw oedema on  
day 21 




(Synonym: A. malaccensis) 
Oil (Topical)  
20 µL/ear/time 30 min after 
TPA administration three 
times till 24 h after the TPA 
administration 
TPA-induced ear inflammation  
(Swiss mice) 
 
Significant reduction of ear oedema and  
pro-inflammatory cytokines production. (1.0% 
agarwood oil had an equivalent effect to 
indomethacin).  
Positive control: indomethacin (200 µg/ear). 
42 
Wood Oil hexanoic extract (50 and 
100 mg/kg) 
sub plantar injection  
Carrageenan-induced paw 
oedema (Rats) 
58.6 and 62.11% inhibition in paw oedema after 3 
h 




Agarwood (65) β-caryophyllene 
 
Carrageenan-induced rat hind 
paw edema model  
(Sprague Dawley Rats) 
(65) 56.2, 71.4, and 87.6% inhibition in paw 
oedema 




































Fig. 1 — Chemical structures of anti-inflammatory compounds isolated from Aquilaria species. The number indicated for each compound 
correspond to the number in the text. 
 
Aquilaria sinensis 
The anti-inflammatory potency of A. sinensis 
ethanolic leaf extract was evaluated using in vivo and 
in vitro models
19
. Using mice as an animal model, the 
extract demonstrated inhibition the xylene-induced 
ear swelling (848 mg/kg, 49.5%), carrageenan-
induced paw oedema (424 mg/kg, 25.02%), and 
carboxymethyl cellulose sodium (CMC-Na)-induced 
leukocyte emigration (848 mg/kg, 90.60%)
19
. 
Meanwhile, in in vitro study, the NO production 
induced by LPS was reduced by the extract in a 
concentration-dependent manner with an IC50 of  






. Flavonoids and benzophenone glycosides 
are majorly found in the aerial parts of the plants such 
as leaves and flowers and are considered to  
possess anti-inflammatory activity. For instance, the 
benzophenone glycosides (1-3) and the flavonoids  
(4-8) isolated from the ethanolic extract of A. sinensis 
leaves demonstrated inhibition against PMA-induced 
polymorphonuclear neutrophils respiratory burst with 
an IC50 values ranging from 0.80 to 89.92 μmol/l
26
. 
Aquisiflavoside flavonoid (9) was also isolated from 
A. sinensis leaves and showed potent inhibition of 




The bioactive constituents of the resinous 
heartwood of A. sinensis were determined and 
multiple chromones and sesquiterpenoids with anti-
inflammatory activities were identified. Chen et al. 
discovered novel chromone derivatives in A. sinensis 
resinous heartwood identified as aquilarones (A – I) 
and another two analogues (10-20) which were 
reported to exhibit potent inhibitory activity against 
LPS-induced NO production in RAW 264.7 cells, 
with an IC50 between 5.12–22.26 µM
28
. Similarly, two 
other chromones (21, 22) were isolated from 
agarwood produced through agarwood-inducing 
techniques demonstrated moderate to significant anti-
inflammatory activity with an IC50 (4.6 and 84 µM), 
respectively
29
. The sesquiterpenoid (23) was also 
identified in A. sinensis heartwood and reported to 
have observable anti-inflammatory activity against 
LPS-induced NO production with an IC50 value of  
8.1 µM
30
. The ethyl acetate fraction obtained from 
95% ethanolic extract of A. sinensis agarwood 
demonstrated potent inhibition of NO production at a 
concentration of 20 µg/mL
31
. The chromones isolated 
by the same researchers in two different studies were 
tested for their anti-inflammatory activity against 
LPS-induced NO production by RAW 264.7 cells, 
and the compounds (24-41) showed inhibition of NO 
production with an IC50 (1.6 µM – 12 µM)
31,32
. The 
anti-inflammatory activity of the aforementioned 
compounds can be attributed to the presence of 
chlorine atom (24-27) and the epoxy group (29) on 
the A-ring
31
 or the dioxepine moiety as in compounds 
(40) and (41)
32
. In another recent study, many 
chromones (42-45) and sesquiterpenoids (46-48) that 
were isolated from ethyl acetate fraction obtained 
from the methanolic extract of the resinous agarwood 
of A. sinensis were tested for their ability to suppress 
LPS-induced NF-KB activation correlated with 
luciferase gene reporter expression
33
. Some of the 
isolated compounds were reported to reduce 
Luciferase activity. Besides, the chromones showed 
an extra ability to inhibit NO production in  
RAW 264.7 macrophages over sesquiterpenoids
33
.  
The strongest compound was 6,7-dimethoxy-2-(2-
phenylethyl) chromone (44) which showed the lowest 
relative luciferase activity (0.31±0.05)
33
. It is possible 
that the presence of two Methoxy (-OCH3)  
groups supports the surpassing inhibition of NF-KB 
activation of compound (44) over compounds (43) 
and (45) with single and triple Methoxy groups, 
respectively. To search for more 2-(2-phenylethyl) 
chromones with potent anti-inflammatory activity, 
Huo et al. conducted a recent study that resulted in the 
discovery of eleven compounds (49-59) that showed 
inhibition of NO production in LPS-stimulated RAW 
264.7 cells with an IC50 ranging from 0.6–37.1 μM
34
. 
The stem barks for A. sinensis were also 
investigated for their anti-inflammatory activity. 
Some of the chromatographically isolated flavones 
(60), chromones (61-66) and sesquiterpenoids (67) 
were reported to have strong inhibitory effects against 
superoxide anion generation and elastase release  
in fMLP/CB-activated human neutrophils, with 
compounds (61-63) shown to be most effective
21
. The 
methanolic extract of the flower buds of A. sinensis 
demonstrated moderate inhibition of NO production 
and comprises benzophenone glycosides (57, 58), that 
showed weak inhibition of NF-KB
35
. The pericarp of 
A. sinensis was also tested for its anti-inflammatory 
activity and some of the isolated compounds (63, 70, 






Relatively few studies have been conducted to 
assess the anti-inflammatory activity of A. malaccensis 
extracts or isolated compounds. 4’-hydroxyacetanilide 
(72) or acetaminophen, which is a well-known anti-
inflammatory agent, was determined in A. malaccensis 
leaves extract obtained by hydrodistillation
37
.  
A preliminary study demonstrated the ability of 
different A. malaccensis leaves extracts to inhibit 
albumin denaturation as a potential sign of anti-
inflammatory effect
38
. Meanwhile, phorbol esters 
discovered in A. malccensis seed extract demonstrated 
anti-inflammatory activity by inhibiting elastase release 
in human neutrophils (73-75)
39
. On the contrary, some 
phorbol esters induced inflammation by enhancing the 
generation of superoxide anions. The study added a 
new notion to the literature on the dual role of phorbol 
esters in the inflammation process. 





The anti-inflammatory activity of A. agallocha was 
observed in vivo against Carrageenan induced paw 
oedema in rats and cotton pellets induced granuloma, 
revealing statistically significant results up to 56.25% 
inhibition in paw oedema at a dose of 200 mg/kg
40
.  
It was also stated that A. agallocha oil demonstrated 
in vivo and in vitro anti-inflammatory activity which is 
comparable to standard diclofenac
41
. Another in vivo 
study concluded that topical treatment with agarwood 
oil obtained from A. agallocha significantly reduced 
oedema and pro-inflammatory cytokines production 
(IL-1β, IL-6, and TNF-α) in TPA-induced mouse ear 
inflammation model which validates its use as an anti-
inflammatory topical medication
42
. The anti-arthritic 
activity of A. agallocha was studied in vitro  
using BSA denaturation assay and in vivo using  
Freund's adjuvant-induced arthritic rat model
43
.  
The findings of both in vitro and in vivo assays 
revealed that the ethanolic extract of A. agallocha 
leaves and heartwood oil exhibited strong  
anti-inflammatory activity. Further details can be 
described in Table 1. 
 
Aquilaria crassna 
Studies on A. crassna showed its remarkable anti-
inflammatory activity. For instance, the ethyl acetate 
extract of A. crassna demonstrated anti-inflammatory 
response through inhibition of TNF-α production
44
. β-
caryophyllene (76) isolated from A. crassna essential 
oils was proven to have anti-inflammatory activity in 
vivo
45
. However, the leaves extract of A. crassna 
failed to demonstrate any anti-inflammatory effect at 




Miscellaneous common compounds with anti-inflammatory 
activity 
In addition to the aforementioned compounds 
discovered in Aquilaria species, Hexadecanoic acid 
(77), which is a well-known anti-inflammatory 
compound, was predominant in the characterization of 
almost all extracts of Aquilaria species. Initial studies 
confirmed that Hexadecanoic acid controls 
inflammation through inhibition of phospholipase A2 
enzyme by binding to its active site
46
. Hexadecanoic 
acid was found as a major compound in the extracts 
of A. malaccensis leaves
38,47
, essential oil of A. 
sinenis, A. crassna and A. agallocha
48-50
. Yet, there is 
no specific study in literature targeting the anti-
inflammatory activity of Hexadecanoic acid isolated 
from Aquilaria species in vivo or in vitro. Likewise, 
phytol (78), diterpene alcohol with reported anti-
inflammatory activity
51
, appeared in the GCMS of 





Few studies have been conducted to examine the 
safe consumption of herbal extracts and the possible 
toxic effects of Aquilaria extracts. Zhou et al. 
reported the relative safety of A. sinensis leaf extract 
when administered in mice intra-gastrically with a 
maximum tolerated dose of 20.4 g/kg
19
. The essential 
oil, hexane and methanol extracts of A. sinensis,  
A. malaccensis, and A. crassna leaves have been 
tested against human’s peripheral blood mononuclear 
cells (PBMCs) using MTT assay for cytotoxicity and 
comet assay for genotoxicity
52
. It has been shown that 
no cytotoxic or genotoxic effects were reported upon 
testing the essential oils and the extracts of the three 
species, except for the methanolic leaf extract of A. 
malaccensis which reported slight toxicity
52
. On the 
contrary, Liyana et al. reported that the methanolic 
extract of A. malaccensis leaves demonstrated no 
signs of acute or sub-chronic toxicity when 
administered orally in rats
53
. The ethanolic leaf extract 
and oil obtained from A. agallocha wood was safe up 
to a dose of 2000 mg/kg in rats when tested following 
the OECD 423 protocol for testing chemicals
41,43
. In 
an acute oral toxicity study in mice following the 
same protocol, the ethanolic extract of A. crassna 
leaves showed no signs of toxicity
54
. In another study, 
the methanolic leaf extract of A. crassna was found to 
be safe with repeated oral doses up to 8000 mg/kg
46
. 
The ethyl acetate extract of A. crassna was found not 
to exert any cytotoxicity of human peripheral blood 
mononuclear cells at a dose of ≥1.5 mg/mL
44
. 
Interestingly, Alam et al. testified that the  
ethanolic extract of A. agallocha leaves exerted a 





Current aspects and future prospects 
In the present review, our attempt was not only to 
summarize the research studies on the anti-
inflammatory effects of Aquilaria, but also to pinpoint 
areas that require further investigations aiming to 
highlight possible developments that will eventually 
lead to advancements in prevention or treatment of 
inflammatory disorders.  
Based on prior research, the four species included in 
this article were proven to exhibit anti-inflammatory 
activities. Some issues are associated with the 
nomenclature of A. agallocha. It is worth to highlight 
that the studies included in this article about this 




species were supported with voucher specimen from 
recognized herbariums to confirm the identification of 
the species unless otherwise mentioned. 
An inadequate number of studies has been 
published on the anti-inflammatory activity of 
different parts of Aquilaria. From Tables 1 and 2, it is 
obvious that a greater number of studies were 
performed on A. sinensis than the three other species 
in the focus area of this review. Besides, the highly 
valuable agarwood resin received more attention by 
researchers in former studies than other parts of the 
tree which have not yet been evaluated for their anti-
inflammatory activity. Fig. 2 shows the number of 
anti-inflammatory studies conducted on each species 
reported between the years 2007-2019. Assumptions 
about the action of drugs in humans can be anticipated 
once-promising in vitro and in vivo findings have 
been achieved. Based on the current review, 19  
in vitro studies and 7 in vivo studies have been carried 
out to identify the anti-inflammatory activity of 
Aquilaria. The in vivo studies are narrow and limited 
compared to the in vitro studies. Since inflammation 
is a vascular phenomenon, research directed towards 
in vivo studies would be more informative. More 
planned in vitro and in vivo studies to provide insights 
into the anti-inflammatory effect of Aquilaria species 
are hypothesized to be beneficial. The researchers 
have used several analytical methods to assess the 
anti-inflammatory property of the plant. The LPS-
induced NO production in RAW 264.7 is the most 
commonly used method in vitro. Animal models used 
in vivo were mainly rats and mice. Other animal 
models such as zebrafish are recommended for further 
studies. 
According to the findings, the anti-inflammatory 
properties of Aquilaria extracts and recognized 
compounds qualify the genus to become an attractive 
anti-inflammatory agent. It is concluded that the 
species exert their anti-inflammatory effect by 
interfering with inflammatory pathways and/or 
suppression of inflammatory mediators. The species, 
the parts investigated and the methods of extraction 
are among the factors that influence the anti-
inflammatory response and the isolated compounds. 
The species-derived compounds that are majorly 
responsible for the anti-inflammatory activity  
are Chromones, sesquiterpenoids, flavonoids, 
benzophenones and phorbol esters. To date, almost  
78 anti-inflammatory compounds were identified. 
However, more isolated compounds can be further 
discovered by targeting other parts of the plant and 
can be assessed for suppressing inflammatory-related 
disorders.  
Toxicological studies carried out on Aquilaria 
species are still deficient. Most studies confirmed the 
safe use of different extracts of the plant. To a lesser 
extent, other evidence revealed that extracts from 
certain Aquilaria species could be unsafe to humans. 
Therefore, further examination of the toxicological 
effects is still needed to provide guidelines for their 
safe intake. 
Deeper research into the phytochemical 
composition of the parts that are not yet explored is 
needed and may introduce new compounds able to 
ameliorate inflammatory responses. It is likewise 
essential to identify the mechanism by which the  
anti-inflammatory actions are attained for future 
studies that can involve synergism between different 
mechanisms. The relationship between the chemical 
structures of the active compounds and their 
pharmacokinetics need to be identified to develop 
their clinical use. The information assembled from 




Extensive researches are directed towards finding 
natural lead compounds for the treatment of 
inflammatory disorders. The review of the 
aforementioned studies not only provided evidence on 
the anti-inflammatory potential of Aquilaria but also 
would be beneficial to the future studies and 
exploitation of different parts of the plant as a 
potential source for treatment and prevention of 
inflammatory-associated disorders. Aquilaria species 
 
 
Fig. 2 — Relative anti-inflammatory studies performed on 
different parts of selected Aquilaria species reported between the 
years 2007-2019 




were investigated for their anti-inflammatory activity 
in vitro and in vivo, and the results qualified Aquilaria 
tree to become a natural source for anti-inflammatory 
drugs. The present report is considered the first 
comprehensive review of the anti-inflammatory 
activity of Aquilaria. Based on the investigated parts 
of different species and the isolated compounds, the 
report highlighted certain gaps that can be areas for 
further studies.  
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